Cell Reports (Mar 2014)

Autocrine Effects of Tumor-Derived Complement

  • Min Soon Cho,
  • Hernan G. Vasquez,
  • Rajesha Rupaimoole,
  • Sunila Pradeep,
  • Sherry Wu,
  • Behrouz Zand,
  • Hee-Dong Han,
  • Cristian Rodriguez-Aguayo,
  • Justin Bottsford-Miller,
  • Jie Huang,
  • Takahito Miyake,
  • Hyun-Jin Choi,
  • Heather J. Dalton,
  • Cristina Ivan,
  • Keith Baggerly,
  • Gabriel Lopez-Berestein,
  • Anil K. Sood,
  • Vahid Afshar-Kharghan

DOI
https://doi.org/10.1016/j.celrep.2014.02.014
Journal volume & issue
Vol. 6, no. 6
pp. 1085 – 1095

Abstract

Read online

We describe a role for the complement system in enhancing cancer growth. Cancer cells secrete complement proteins that stimulate tumor growth upon activation. Complement promotes tumor growth via a direct autocrine effect that is partially independent of tumor-infiltrating cytotoxic T cells. Activated C5aR and C3aR signal through the PI3K/AKT pathway in cancer cells, and silencing the PI3K or AKT gene in cancer cells eliminates the progrowth effects of C5aR and C3aR stimulation. In patients with ovarian or lung cancer, higher tumoral C3 or C5aR mRNA levels were associated with decreased overall survival. These data identify a role for tumor-derived complement proteins in promoting tumor growth, and they therefore have substantial clinical and therapeutic implications.